by PEIBioAlliance | Apr 30, 2020 | Clients, News
April 30, 2020– [Emergence Client] Alpha Cognition Inc. (ACI) [formerly Neurodyn Cognition] today announced that in a pre-Investigational New Drug (Pre-IND) meeting, the U.S. Food and Drug Administration (USFDA) agreed upon a clinical and regulatory pathway for the...
by PEIBioAlliance | Apr 29, 2020 | Cannabis, Clients
Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the derivative cannabis market, is pleased to announce that its wholly-owned subsidiary Dosecann LD Inc. (“Dosecann”) has entered into an...
by PEIBioAlliance | Apr 28, 2020 | Cannabis, Clients
Two Emergence clients: Dosecann and Nature’s Crops Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the derivative cannabis market, is pleased to announce that its wholly owned...
by PEIBioAlliance | Apr 28, 2020 | Clients, COVID-19 News
Reprinted from CBC Prince Edward Island. The story was also featured on CBC Compass evening TV news program. A Charlottetown biotech company has joined the fight against COVID-19 by creating antibodies that could help detect the presence of the virus in humans. The...
by PEIBioAlliance | Apr 24, 2020 | Clients, News
As essential service staff work long hours and families distance themselves from others by hunkering down in their homes, bioscience companies and their employees are flexing their research, development and manufacturing muscle to help in the fight against COVID-19....
by PEIBioAlliance | Mar 25, 2020 | Clients
Dr. Gordon’s Bum Cream company has been chosen to participate in Praxis Spinal Cord Institute’s Praxis SCI Accelerate Program, a 12-week acceleration pilot program for health start-up companies with solutions that address care- and cure-related treatments...
